FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:1271-1281 March 20, 2008 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text PowerPoint Slide Set CME Exam Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

Acinetobacter is a gram-negative coccobacillus (Figure 1)^1,2 that during the past three decades has emerged from an organism of questionable pathogenicity to an infectious agent of importance to hospitals worldwide.^3,4 Approximately one quarter of the PubMed citations for "nosocomial acinetobacter" in the past 20 years appeared in 2005 and 2006. Acinetobacter infections have long been clinically prominent in tropical countries, have been a recurrent problem during wars and natural disasters, and have recently caused multihospital outbreaks in temperate climates. Most alarming are the organism's ability to accumulate diverse mechanisms of resistance, the emergence of strains that are resistant . . . [Full Text of this Article]

Mechanisms of Resistance

Epidemiology

Health Care–Associated Infections

Seasonal Variation

Community-Acquired Infections

Military Personnel

Disasters

Clinical Manifestations

Treatment

Infection Control

Source Information

From Medical Specialists, Dyer, IN (L.S.M.-P.); and the Division of Infectious Diseases, Stroger (Cook County) Hospital, Ruth M. Rothstein CORE Center, and Rush Medical College — all in Chicago (R.A.W.).

Address reprint requests to Dr. Munoz-Price at Medical Specialists, 919 Main St., Ste. 202, Dyer, IN 46311, or at simunozprice@gmail.com.

Related Letters:

Acinetobacter Infection
Kapoor R., Myrianthefs P., Gavala A., Baltopoulos G., Lima A. L., Oliveira P. R., Paula A. P., Munoz-Price L. S., Weinstein R. A.
Extract | Full Text | PDF  
N Engl J Med 2008; 358:2845-2847, Jun 26, 2008. Correspondence

This article has been cited by other articles:

• Adams, M. D., Nickel, G. C., Bajaksouzian, S., Lavender, H., Murthy, A. R., Jacobs, M. R., Bonomo, R. A. (2009). Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System. Antimicrob. Agents Chemother. 53: 3628-3634 [Abstract] [Full Text]  
• Figueiredo, S., Poirel, L., Papa, A., Koulourida, V., Nordmann, P. (2009). Overexpression of the Naturally Occurring blaOXA-51 Gene in Acinetobacter baumannii Mediated by Novel Insertion Sequence ISAba9. Antimicrob. Agents Chemother. 53: 4045-4047 [Full Text]  
• Hujer, K. M., Hujer, A. M., Endimiani, A., Thomson, J. M., Adams, M. D., Goglin, K., Rather, P. N., Pennella, T.-T. D., Massire, C., Eshoo, M. W., Sampath, R., Blyn, L. B., Ecker, D. J., Bonomo, R. A. (2009). Rapid Determination of Quinolone Resistance in Acinetobacter spp.. J. Clin. Microbiol. 47: 1436-1442 [Abstract] [Full Text]  
• Lu, P.-L., Doumith, M., Livermore, D. M., Chen, T.-P., Woodford, N. (2009). Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase. J Antimicrob Chemother 63: 641-647 [Abstract] [Full Text]  
• Adams-Haduch, J. M., Paterson, D. L., Sidjabat, H. E., Pasculle, A. W., Potoski, B. A., Muto, C. A., Harrison, L. H., Doi, Y. (2008). Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in Pennsylvania. Antimicrob. Agents Chemother. 52: 3837-3843 [Abstract] [Full Text]  
• Kapoor, R., Myrianthefs, P., Gavala, A., Baltopoulos, G., Lima, A. L., Oliveira, P. R., Paula, A. P., Munoz-Price, L. S., Weinstein, R. A. (2008). Acinetobacter Infection. NEJM 358: 2845-2847 [Full Text]